Comparison of Insulin Degludec With Insulin Glargine in Subjects With Type 1 Diabetes Mellitus
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
This trial was conducted in Europe. The aim of this trial was to compare the pharmacodynamic
(the effect of the investigated drug on the body) response of insulin degludec (insulin 454)
with insulin glargine at steady-state conditions in subjects with type 1 diabetes mellitus.